Stockscreener 앱 받기
3.98
3.11%
0.12
시간 외 거래:
3.80
-0.18
-4.52%
전일 마감가:
$3.86
열려 있는:
$3.91
하루 거래량:
20,506
Relative Volume:
0.46
시가총액:
$38.18M
수익:
-
순이익/손실:
$-19.09M
주가수익비율:
-2.236
EPS:
-1.78
순현금흐름:
$-17.24M
1주 성능:
+12.43%
1개월 성능:
+35.37%
6개월 성능:
+3.65%
1년 성능:
-41.56%
1일 변동 폭
$3.8522
$4.05
1주일 범위
$3.55
$4.4336
52주 변동 폭
$2.55
$6.81
Lantern Pharma Inc Stock (LTRN) Company Profile
명칭
Lantern Pharma Inc
전화
972-277-1136
주소
1920 MCKINNEY AVENUE, DALLAS, TX
LTRN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LTRN
Lantern Pharma Inc
|
3.98 | 38.18M | 0 | -19.09M | -17.24M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-10-07 | 개시 | H.C. Wainwright | Buy |
Lantern Pharma Inc 주식(LTRN)의 최신 뉴스
Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET - BioSpace
Lantern Pharma to Report First Quarter 2025 Operating & Financial Results on May 15th, 2025 at 9:00 a.m. ET | LTRN Stock News - GuruFocus
Ion Pure Review: Is IonPure The Best Air Purifier Of 2025? - Barchart.com
Soybeans Continue Slide On Tuesday - Barchart.com
Pastor Ryan Macdonald Shares His Journey of Faith and Leadership in Exclusive Online Interview - Barchart.com
Entrepreneur Brandon Erickson From Wisconsin Featured In Exclusive Interview Spotlight - Barchart.com
Maneskin Store Launches 2025 Summer Collection For Rock Fans Worldwide - Barchart.com
OSC Analysis Highlights Increasing Mentions And Diverging Sentiment In AI Disclosures - Barchart.com
Cotton Lower At Midday - Barchart.com
Mining Companies Recognized For Excellence In Responsible Mining - Barchart.com
No Bull | The Five Spot - Barchart.com
LTRN: IND Clearance for LP-184 in TNBC - MSN
East Side Games Group To Announce First Quarter 2025 Financial Results - Barchart.com
Soybeans Holding Tuesday AM Losses As Fast Plant Pace Continues - Barchart.com
Bell Unveils Tech Services Brand Ateko, Merging Three Recently Acquired Companies - Barchart.com
Natural Gas Slowed Down For A Correction Within Uptrend - Barchart.com
IBM Accelerates Enterprise Gen AI Revolution With Hybrid Capabilities - Barchart.com
2 Reasons To Like S And 1 To Stay Skeptical - Barchart.com
Corn Collapses Towards April Lows On Monday - Barchart.com
Car Haggle Helper Launches No-Risk Service That Saves New Car Buyers $4 – $8K on Average - Barchart.com
Lucintel Forecasts The Global MRD Testing Market To Reach $3.4 Billion By 2031 - Barchart.com
Wellesley Homes Get A Touch Of Glam With IDEAL Showers - Barchart.com
Powersolv, Inc. Announces Headquarters Relocation To Montgomery County, Maryland - Barchart.com
Dollar Moves Lower And Gold Rallies On US Trade Uncertainty - Barchart.com
Recovery Support In Muskoka: A Closer Look At Rehabilitation Services In Ontario - Barchart.com
Soybeans Facing Pressure On Monday - Barchart.com
Avizle Launches New Platform To Streamline Visa Applications For Indian Travelers - Barchart.com
Lantern Pharma (LTRN) Gets FDA Green Light to Begin Human Trials for New Breast Cancer Drug - Barchart.com
Florida Jury Awards Man $3M For Defective Airbag That Caused Serious Injury During Crash - Barchart.com
Lantern Pharma (LTRN) Gains FDA Approval for Clinical Trial in Breast Cancer | LTRN Stock News - GuruFocus
Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC) | LTRN Stock News - GuruFocus
Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC) - Business Wire
Cattle Look To New Week, After A Week Of Cash Strength - Barchart.com
Lantern Pharma Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
AgJunction Sets Third Quarter 2021 Conference Call for Monday, November 15, 2021, at 11:00 a.m. ET - Barchart.com
Elon Musk’s rocket launch site Starbase on its way to becoming a Texas city after lopsided early voting results - Barchart.com
The Ventures Award Expands Global Presence In 2025, Spotlighting Excellence In Early-Stage Innovation - Barchart.com
Katharina Muller Drives AI Financial Innovation - Barchart.com
Tech Weakness Meets Trade Optimism—Will Bulls Regain Control? - Barchart.com
COFOMO WELCOMES EPERFORMANCE TO ITS TEAM - Barchart.com
Plaque To Mark Safe Return Of 'Lucky 7' Newfoundland Fishers After Days Adrift At Sea - Barchart.com
RCMP In Eastern Newfoundland Take Over Search For Pilot Of Downed Small Plane - Barchart.com
McDonald's store traffic falls unexpectedly to start the year as diners grow increasingly uneasy over the economy - Barchart.com
Moderna: Q1 Earnings Snapshot - Barchart.com
Lantern Pharma (LTRN) to Release Quarterly Earnings on Thursday - Defense World
STATEMENTCMA Marks National Physicians' Day - Barchart.com
What You Need To Know Ahead Of McCormick & Company's Earnings Release - Barchart.com
Hogs Fall Weaker On Wednesday - Barchart.com
This Company Extended Its Post-Earnings Rally To Record Highs - Barchart.com
CPG To Attend 9th Annual American Supply Chain Summit In Dallas - Barchart.com
Microsoft Pledges To Protect European Operations And Unveils Data Center Expansion - Barchart.com
Lantern Pharma Inc (LTRN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lantern Pharma Inc 주식 (LTRN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Fletcher Aaron G.L. | 10% Owner |
May 23 '24 |
Sale |
6.25 |
10,000 |
62,500 |
59,326 |
0.84%
0.15%
자본화:
|
볼륨(24시간):